Febuxostat

被引：67

作者：

Pascual, Eliseo ^{[1
]}

Sivera, Francisca ^{[1
]}

Yasothan, Uma ^{[2
]}

Kirkpatrick, Peter

机构：

[1] Univ Miguel Hernandez, Hosp Gen Univ Alicante, Alicante, Spain

[2] IMS Hlth, London NW1 6JB, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 03期

关键词：

XANTHINE-OXIDASE INHIBITOR; GOUT; HYPERURICEMIA; ALLOPURINOL; URATE; MANAGEMENT; TEI-6720;

D O I：

10.1038/nrd2831

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 [微生物学]; 090105 [作物生产系统与生态工程];

摘要：

In May 2008, febuxostat (Adenuric; Ipsen), an inhibitor of xanthine oxidase, was granted marketing authorization by the European Commission for the treatment of chronic hyperuricaemia in conditions in which urate deposition has occurred, such as gouty arthritis.

引用

页码：191 / 192

页数：2

共 15 条

[1]

Febuxostat compared with allopurinol in patients with hyperuricemia and gout [J].

Becker, MA ;

Schumacher, HR ;

Wortmann, RL ;

MacDonald, PA ;

Eustace, D ;

Palo, WA ;

Streit, J ;

Joseph-Ridge, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2450-2461

[2]

Pathogenesis of gout [J].

Choi, HK ;

Mount, DB ;

Reginato, AM .

ANNALS OF INTERNAL MEDICINE, 2005, 143 (07) :499-516

[3]

*EMEA, 2008, EUR PUBL ASS REP AD

[4]

HAUBER A, 2008, BEAR STERNS EQUITY R

[5]

HYPOURICEMIC EFFECT OF ALLOPURINOL AND THE NOVEL XANTHINE-OXIDASE INHIBITOR TEI-6720 IN CHIMPANZEES [J].

KOMORIYA, K ;

OSADA, Y ;

HASEGAWA, M ;

HORIUCHI, H ;

KONDO, S ;

COUCH, RC ;

GRIFFIN, TB .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (03) :455-460

[6]

Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD) [J].

Mikuls, TR ;

Farrar, JT ;

Bilker, WB ;

Fernandes, S ;

Saag, KG .

RHEUMATOLOGY, 2005, 44 (08) :1038-1042

[7]

An extremely potent inhibitor of xanthine oxidoreductase - Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition [J].

Okamoto, K ;

Eger, BT ;

Nishino, T ;

Kondo, S ;

Pai, EF ;

Nishino, T .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1848-1855

[8]

HYPOURICEMIC EFFECT OF THE NOVEL XANTHINE-OXIDASE INHIBITOR, TEI-6720, IN RODENTS [J].

OSADA, Y ;

TSUCHIMOTO, M ;

FUKUSHIMA, H ;

TAKAHASHI, K ;

KONDO, S ;

HASEGAWA, M ;

KOMORIYA, K .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 241 (2-3) :183-188

[9]

Therapeutic advances in gout [J].

Pascual, Eliseo ;

Sivera, Francisca .

CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (02) :122-127

[10]

Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout [J].

Pascual, Eliseo ;

Sivera, Francisca .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (08) :1056-1058

← 1 2 →